Physiological Reviews,
Journal Year:
2019,
Volume and Issue:
100(1), P. 171 - 210
Published: Sept. 5, 2019
Fatty
acids
are
metabolized
and
synthesized
as
energy
substrates
during
biological
responses.
Long-
medium-chain
fatty
derived
mainly
from
dietary
triglycerides,
short-chain
(SCFAs)
produced
by
gut
microbial
fermentation
of
the
otherwise
indigestible
fiber,
constitute
major
sources
free
(FFAs)
in
metabolic
network.
Recently,
increasing
evidence
indicates
that
FFAs
serve
not
only
but
also
natural
ligands
for
a
group
orphan
G
protein-coupled
receptors
(GPCRs)
termed
acid
(FFARs),
essentially
intertwining
metabolism
immunity
multiple
ways,
such
via
inflammation
regulation
secretion
peptide
hormones.
To
date,
several
FFARs
activated
various
chain
lengths
have
been
identified
characterized.
In
particular,
FFAR1
(GPR40)
FFAR4
(GPR120)
long-chain
saturated
unsaturated
acids,
while
FFAR3
(GPR41)
FFAR2
(GPR43)
SCFAs,
acetate,
butyrate,
propionate.
this
review,
we
discuss
recent
reports
on
key
physiological
functions
FFAR-mediated
signaling
transduction
pathways
immune
We
attempt
to
reveal
future
research
opportunities
developing
therapeutics
disorders.
Physiological Reviews,
Journal Year:
2019,
Volume and Issue:
99(4), P. 1877 - 2013
Published: Aug. 28, 2019
The
importance
of
the
gut-brain
axis
in
maintaining
homeostasis
has
long
been
appreciated.
However,
past
15
yr
have
seen
emergence
microbiota
(the
trillions
microorganisms
within
and
on
our
bodies)
as
one
key
regulators
function
led
to
appreciation
a
distinct
microbiota-gut-brain
axis.
This
is
gaining
ever
more
traction
fields
investigating
biological
physiological
basis
psychiatric,
neurodevelopmental,
age-related,
neurodegenerative
disorders.
brain
communicate
with
each
other
via
various
routes
including
immune
system,
tryptophan
metabolism,
vagus
nerve
enteric
nervous
involving
microbial
metabolites
such
short-chain
fatty
acids,
branched
chain
amino
peptidoglycans.
Many
factors
can
influence
composition
early
life,
infection,
mode
birth
delivery,
use
antibiotic
medications,
nature
nutritional
provision,
environmental
stressors,
host
genetics.
At
extreme
diversity
diminishes
aging.
Stress,
particular,
significantly
impact
at
all
stages
life.
Much
recent
work
implicated
gut
many
conditions
autism,
anxiety,
obesity,
schizophrenia,
Parkinson’s
disease,
Alzheimer’s
disease.
Animal
models
paramount
linking
regulation
fundamental
neural
processes,
neurogenesis
myelination,
microbiome
activation
microglia.
Moreover,
translational
human
studies
are
ongoing
will
greatly
enhance
field.
Future
focus
understanding
mechanisms
underlying
attempt
elucidate
microbial-based
intervention
therapeutic
strategies
for
neuropsychiatric
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: March 11, 2019
Ulcerative
colitis
(UC)
and
Crohn's
disease
(CD),
collectively
known
as
Inflammatory
Bowel
Diseases
(IBD),
are
caused
by
a
complex
interplay
between
genetic,
immunologic,
microbial
environmental
factors.
Dysbiosis
of
the
gut
microbiome
is
increasingly
considered
to
be
causatively
related
IBD
strongly
affected
components
Western
life
style.
Bacteria
that
ferment
fibers
produce
short
chain
fatty
acids
(SCFAs)
typically
reduced
in
mucosa
feces
patients
with
IBD,
compared
healthy
individuals.
SCFAs,
such
acetate,
propionate
butyrate,
important
metabolites
maintaining
intestinal
homeostasis.
Several
studies
have
indeed
shown
fecal
SCFAs
levels
active
IBD.
an
fuel
for
epithelial
cells
strengthen
barrier
function.
Recent
findings,
however,
show
particular
also
immunomodulatory
functions.
Absorption
facilitated
substrate
transporters
like
MCT1
SMCT1
promote
cellular
metabolism.
Moreover,
may
signal
through
cell
surface
G-protein
coupled
receptors
(GPCRs),
GPR41,
GPR43,
GPR109A,
activate
signaling
cascades
control
immune
Transgenic
mouse
models
support
key
role
these
GPCRs
controlling
inflammation.
Here,
we
present
overview
production
their
effects
on
specific
emphasis
relevance
discuss
therapeutic
potential
either
applied
directly
or
stimulating
SCFAs-producing
bacteria
pre-
probiotic
approaches.
Biochemical Journal,
Journal Year:
2017,
Volume and Issue:
474(11), P. 1823 - 1836
Published: May 16, 2017
The
human
gastrointestinal
(GI)
tract
harbours
a
complex
and
dynamic
population
of
microorganisms,
the
gut
microbiota,
which
exert
marked
influence
on
host
during
homeostasis
disease.
Multiple
factors
contribute
to
establishment
microbiota
infancy.
Diet
is
considered
as
one
main
drivers
in
shaping
across
life
time.
Intestinal
bacteria
play
crucial
role
maintaining
immune
metabolic
protecting
against
pathogens.
Altered
bacterial
composition
(dysbiosis)
has
been
associated
with
pathogenesis
many
inflammatory
diseases
infections.
interpretation
these
studies
relies
better
understanding
inter-individual
variations,
heterogeneity
communities
along
GI
tract,
functional
redundancy
need
distinguish
cause
from
effect
states
dysbiosis.
This
review
summarises
our
current
development
its
impact
integrity
health,
underlying
for
mechanistic
focusing
host–microbe
interactions.
Frontiers in Microbiology,
Journal Year:
2016,
Volume and Issue:
7
Published: Feb. 17, 2016
The
colon
is
inhabited
by
a
dense
population
of
microorganisms,
the
so-called
"gut
microbiota,"
able
to
ferment
carbohydrates
and
proteins
that
escape
absorption
in
small
intestine
during
digestion.
This
microbiota
produces
wide
range
metabolites,
including
short
chain
fatty
acids
(SCFA).
These
compounds
are
absorbed
large
bowel
defined
as
1-6
carbon
volatile
which
can
present
straight
or
branched-chain
conformation.
Their
production
influenced
pattern
food
intake
diet-mediated
changes
gut
microbiota.
SCFA
have
distinct
physiological
effects:
they
contribute
shaping
environment,
influence
physiology
colon,
be
used
energy
sources
host
cells
intestinal
also
participate
different
host-signaling
mechanisms.
We
summarize
current
knowledge
about
SCFA,
bacterial
cross-feedings
interactions,
biological
properties
these
metabolites
with
impact
on
human
health.
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(5), P. 1474 - 1474
Published: May 19, 2020
The
gut
microbiota
is
emerging
as
a
promising
target
for
the
management
or
prevention
of
inflammatory
and
metabolic
disorders
in
humans.
Many
current
research
efforts
are
focused
on
identification
specific
microbial
signatures,
more
particularly
those
associated
with
obesity,
type
2
diabetes,
cardiovascular
diseases.
Some
studies
have
described
that
obese
animals
humans
exhibits
higher
Firmicutes/Bacteroidetes
ratio
compared
normal-weight
individuals,
proposing
this
an
eventual
biomarker.
Accordingly,
frequently
cited
scientific
literature
hallmark
obesity.
aim
present
review
was
to
discuss
validity
potential
marker,
based
great
amount
contradictory
results
reported
literature.
Such
discrepancies
might
be
explained
by
existence
interpretative
bias
generated
methodological
differences
sample
processing
DNA
sequence
analysis,
generally
poor
characterization
recruited
subjects
and,
particularly,
lack
consideration
lifestyle-associated
factors
known
affect
composition
and/or
diversity.
For
these
reasons,
it
currently
difficult
associate
determined
health
status
specifically
consider
Microbial Ecology in Health and Disease,
Journal Year:
2015,
Volume and Issue:
26(0)
Published: Feb. 2, 2015
There
is
growing
evidence
that
dysbiosis
of
the
gut
microbiota
associated
with
pathogenesis
both
intestinal
and
extra-intestinal
disorders.Intestinal
disorders
include
inflammatory
bowel
disease,
irritable
syndrome
(IBS),
coeliac
while
allergy,
asthma,
metabolic
syndrome,
cardiovascular
obesity.In
many
these
conditions,
mechanisms
leading
to
disease
development
involves
pivotal
mutualistic
relationship
between
colonic
microbiota,
their
products,
host
immune
system.The
establishment
a
'healthy'
early
in
life
appears
be
critical
maintaining
homeostasis.Whilst
we
do
not
yet
have
clear
understanding
what
constitutes
picture
emerging
from
recent
studies
identifying
particular
bacterial
species
healthy
microbiota.In
particular,
residing
within
mucus
layer
colon,
either
through
direct
contact
cells,
or
indirect
communication
via
metabolites,
may
influence
whether
cellular
homeostasis
maintained
are
triggered.In
addition
inflammation,
there
some
perturbations
involved
colorectal
cancer.In
this
case,
most
important
factor,
rather
products
interaction
diet
microbiome.High-protein
diets
thought
result
production
carcinogenic
metabolites
induction
neoplasia
epithelium.Ever
more
sensitive
metabolomics
methodologies
reveal
suite
small
molecules
produced
microbiome
which
mimic
act
as
neurosignallers
neurotransmitters.Coupled
probiotic
interventions
alter
psychological
endpoints
humans
rodent
models,
data
suggest
CNS-related
co-morbidities
frequently
GI
originate
intestine
microbial
dysbiosis.This
review
outlines
current
showing
extent
contributes
disease.Based
on
date,
can
assess
potential
positively
modulate
composition
ameliorate
activity
intervention.
Hepatology,
Journal Year:
2015,
Volume and Issue:
63(3), P. 764 - 775
Published: Nov. 24, 2015
Several
animal
studies
have
emphasized
the
role
of
gut
microbiota
in
nonalcoholic
fatty
liver
disease
(NAFLD).
However,
data
about
dysbiosis
human
NAFLD
remain
scarce
literature,
especially
including
whole
spectrum
lesions.
We
aimed
to
evaluate
association
between
and
severe
lesions,
that
is,
steatohepatitis
(NASH)
fibrosis,
a
well-characterized
population
adult
NAFLD.
Fifty-seven
patients
with
biopsy-proven
were
enrolled.
Taxonomic
composition
was
determined
using
16S
ribosomal
RNA
gene
sequencing
stool
samples.
Thirty
had
F0/F1
fibrosis
stage
at
biopsy
(10
NASH),
27
significant
F≥2
(25
NASH).
Bacteroides
abundance
significantly
increased
NASH
patients,
whereas
Prevotella
decreased.
Ruminococcus
higher
patients.
By
multivariate
analysis,
independently
associated
fibrosis.
Stratification
according
these
two
bacteria
generated
three
patient
subgroups
increasing
severity
Based
on
imputed
metagenomic
profiles,
Kyoto
Encyclopedia
Genes
Genomes
pathways
related
mostly
carbohydrate,
lipid,
amino
acid
metabolism.NAFLD
associates
shift
metabolic
function
microbiota.
identified
as
Thus,
analysis
adds
information
classical
predictors
suggests
novel
targets
for
pre-/probiotics
therapies.
Foods,
Journal Year:
2019,
Volume and Issue:
8(3), P. 92 - 92
Published: March 9, 2019
Prebiotics
are
a
group
of
nutrients
that
degraded
by
gut
microbiota.
Their
relationship
with
human
overall
health
has
been
an
area
increasing
interest
in
recent
years.
They
can
feed
the
intestinal
microbiota,
and
their
degradation
products
short-chain
fatty
acids
released
into
blood
circulation,
consequently,
affecting
not
only
gastrointestinal
tracts
but
also
other
distant
organs.
Fructo-oligosaccharides
galacto-oligosaccharides
two
important
groups
prebiotics
beneficial
effects
on
health.
Since
low
quantities
fructo-oligosaccharides
naturally
exist
foods,
scientists
attempting
to
produce
industrial
scale.
Considering
benefits
safety,
as
well
production
storage
advantages
compared
probiotics,
they
seem
be
fascinating
candidates
for
promoting
condition
replacement
or
association
probiotics.
This
review
discusses
different
aspects
prebiotics,
including
crucial
role
well-being.